Related Experiment Video

Updated: Mar 20, 2026

Study of Protein-protein Interactions in Autophagy Research
14:08

Study of Protein-protein Interactions in Autophagy Research

Published on: September 9, 2017

9.7K

Structure-Activity Relationship Studies Enable Optimization of a Small-Molecule Autophagy Activator and Evaluation of

Andrew Dobria1,2, Andrea Arrieche Suarez1,2, Thomas Whitmarsh-Everiss1

  • 1Department of Chemistry, University of Illinois Chicago, Chicago, Illinois 60607, United States.

ACS Pharmacology & Translational Science
|March 19, 2026
PubMed

Insights

Scientists enhanced autophagy activators for disease research. New analogues show improved stability and selectivity, enabling further study in cancer and neurodegenerative disease models.

Area of Science:

  • Cellular biology
  • Molecular mechanisms of disease

Background:

  • Autophagy, a cellular recycling process, is implicated in diseases like cancer and neurodegeneration.
  • Previous research identified initial autophagy activators but noted poor compound stability.
  • Structure-activity relationship studies aimed to enhance activator potency.

Purpose of the Study:

  • To develop novel autophagy activators with improved potency and microsomal stability.
  • To investigate the mechanistic effects of sustained autophagy activation, including cell death.
  • To differentiate analogues based on selectivity and off-target effects.

Main Methods:

  • Iterative synthesis of novel analogues based on initial hit compounds.
  • Mechanistic studies to assess autophagy activation levels and cellular responses.
  • Evaluation of compound stability and selectivity profiles.

Main Results:

  • Development of synthetic strategies yielding analogues with enhanced potency and stability.
  • Identification of autophagy-dependent cell death as a consequence of sustained activation.
  • Differentiation of analogues, highlighting those with improved selectivity.

Conclusions:

  • Novel autophagy activators with superior properties were successfully synthesized.
  • Understanding autophagy's role in disease requires selective and stable chemical probes.
  • Promising analogues are poised for further in vivo evaluation in disease models.
Keywords:
activatorapoptosisautophagyautophagy-dependent cell deathnecrosissmall molecule

More Related Videos

The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells09:34

The Lactate Dehydrogenase Sequestration Assay — A Simple and Reliable Method to Determine Bulk Autophagic Sequestration Activity in Mammalian Cells

Published on: July 27, 2018

18.8K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

1.5K

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.9K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.0K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.4K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K